https://istar-medical.com

Home - iSTAR MedicaliSTAR Medical is a medtech company delivering breakthrough eye care solutions through minimally-invasive implants with bio-integration.Home - iSTAR Medical Treatments MINIject® Clinical program Publications Glaucoma About glaucoma Glaucoma surgery & treatments News & events Latest news Press releases Upcoming events Multimedia gallery iSTAR Medical About us Management team Board of directors Scientific advisors Careers Contact en Home Treatments Glaucoma News & events iSTAR Medical Careers Contact MINIject® Clinical program Publications About glaucoma Glaucoma surgery & treatments Latest news Press releases Upcoming events Multimedia gallery About us Management team Board of directors Scientific advisors Delivering breakthrough eye care solutions MINIject® is seeking to transform the glaucoma treatment landscape with its distinctive, tissue-integrating STAR® material. MINIject® is currently the only commercially available minimally invasive glaucoma surgery (MIGS) implant that enhances natural flow in the supraciliary space, and has been shown to deliver safe, meaningful and sustained control of intraocular pressure (IOP). DISCOVER MINIject ABOUT iSTAR MEDICAL MINIject MINIject® is a novel MIGS device for patients with open-angle glaucoma, made of an innovative medical-grade silicone material called STAR®. MINIject® has been shown to safely and meaningfully control eye pressure and glaucoma through: STAR® material is composed of a multi-channel network of hollow spheres making it soft and flexible while encouraging bio-integration. iSTAR Medical believes this distinctive combination of material and outflow enables MINIject® to deliver sustained efficacy.    MINIject® is only available for sale in the European Union, the UK and Switzerland. Denis P, Hirneiß C, Durr GM, et al. Br J Ophthalmol 2020;0:1–6 SEE MORE ABOUT MINIJECT Glaucoma worldwide glaucoma is the 1 st leading cause of irreversible blindness in the world age 60 + years of age is a major risk factor affecting over 100 million people globally every year, more than 2 million people globally are newly diagnosed with glaucoma in western europe, around 14 % patients undiagnosed up to 74% in emerging markets such as India With a wordwide average 24 % annual growth rate MIGS are the fastest growing glaucoma treatment SEE MORE ABOUT GLAUCOMA Source: Market Scope, “2021 Glaucoma Surgical Device Market Report”, July 2021; Jonas JB, Aung T, Bourne RR et al, “Glaucoma”, Lancet 2017; 390: 2083–93 iSTAR Medical iSTAR Medical is a medtech company committed to delivering breakthrough eye care solutions through minimally-invasive implants designed for bio-integration. Our mission is to become the world leader in minimally invasive implants for glaucoma surgery.   iSTAR Medical received European approval for the MINIject MIGS device in late 2021 and began enrolment into an FDA-approved clinical trial (STAR-V) in the United States in 2021. Since 2023, it is also approved for implantation in Australia.   ABOUT US News items Press releases iSTAR Medical continues to strengthen US presence with appointment of Chief Medical Officer and Vice President of Clinical Affairs READ MORE Press releases iSTAR Medical Expands International Commercial Rollout of MINIject® with Successful First Implants Completed in Australia READ MORE News Celebrating the achievements of 2023 and looking forward to a successful 2024 READ MORE Press releases iSTAR Medical continues European expansion with first MINIject® surgeries in the Netherlands READ MORE Press releases iSTAR Medical conducts first MINIject® surgeries in Ireland, expanding commercial rollout in Europe READ MORE Press releases iSTAR Medical presents positive three-year results for MINIject® from STAR-GLOBAL trial READ MORE Press releases iSTAR Medical expands presence at 10th World Glaucoma Congress with presentation of new three-year interim STAR-GLOBAL data and several presentations READ MORE Press releases 10th May 2023 Over 1000 glaucoma patients now benefiting from iSTAR Medical’s MINIject® READ MORE Press releases 15th March 2023 iSTAR Medical initiates international STAR-VI trial for the use of MINIject in conjunction with cataract surgery READ MORE MORE NEWS Sign up to receive company news alerts E-mail address Subscribe × Sitemap Terms of use Privacy Policy Intranet Contact us © Copyright - iSTAR Medical 2024engben-GB1727807570https://istar-medical.com

Modificare il tuo sito?

Cosa fai?